DNA Manufacturing Market Outlook: Major Segments, Strategic Developments, and Leading Companies

The DNA manufacturing sector is on the brink of significant expansion as technological advancements and increasing applications drive demand. This market is capturing attention for its critical role in gene therapy, vaccine development, and other biopharmaceutical uses, positioning it for strong growth in the coming years. Below, we explore its growth potential, leading players, emerging trends, and market segmentation.

Projected Market Size and Growth Trajectory in the DNA Manufacturing Market
The DNA manufacturing market is anticipated to grow swiftly, reaching a valuation of $11.95 billion by 2030. This corresponds to a compound annual growth rate (CAGR) of 16.4%, reflecting robust demand fueled by several factors. Progress in enzymatic and chemical DNA synthesis technologies, coupled with the expansion of gene therapy and vaccine development pipelines, are key contributors. Additionally, the increasing use of GMP-grade DNA production, growing demand for longer and more complex DNA constructs, and the integration of automated manufacturing platforms and digital workflows are driving this upward trend. Important market trends include rising needs for GMP-grade DNA in therapeutic applications, an uptick in plasmid and synthetic DNA production for vaccines, growing adoption of gene synthesis and codon optimization services, and broader use of oligonucleotide synthesis for PCR, siRNA, and antisense therapies.

Download a free sample of the deoxyribonucleic acid (dna) manufacturing market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Key Factors Stimulating DNA Manufacturing Market Growth
The advancement of enzymatic and chemical DNA synthesis methods is critical for meeting growing industry demands. These innovations enable the production of more precise and varied DNA sequences, supporting a wide range of therapeutic and research applications.
Simultaneously, the expansion of gene therapy and vaccine development pipelines is accelerating demand. As more complex DNA constructs become necessary to support cutting-edge treatments, manufacturers must scale up production capabilities and ensure high-quality standards.

Top Players Driving Innovation in the DNA Manufacturing Market
Several influential companies play a major role in shaping the DNA manufacturing landscape. These include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., and PlasmidFactory GmbH & Co. KG.
A notable development occurred in February 2025 when Maravai LifeSciences Holdings, Inc., a U.S.-based life sciences company, acquired Officinae Bio S.r.l., an Italian biotech firm specializing in AI-driven DNA and RNA sequence design platforms. This acquisition aims to accelerate next-generation nucleic acid therapies by integrating Officinae's AI-enabled mRNA and DNA design tools into Maravai's TriLink nucleic acid production business.

View the full deoxyribonucleic acid (dna) manufacturing market report:
https://www.thebusinessresearchcompany.com/report/deoxyribonucleic-acid-dna-manufacturing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Trends Shaping the Future of DNA Manufacturing
The DNA manufacturing sector is increasingly focusing on GMP-grade plasmid DNA production to meet stringent quality and safety requirements. This approach ensures consistency and scalability for gene and cell therapy applications.
For example, in April 2025, ProBio Genomics Inc., a U.S.-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell. Their offering includes in-house analytical testing, method development, and project management, streamlining the process by minimizing the need for multiple suppliers and accelerating timelines. ProBio's service guarantees high-quality plasmid DNA with =85% supercoiled content while reducing contamination risks. They also provide GMP-like plasmids with a rapid four-week delivery and full GMP-grade plasmids within three months.

Detailed Breakdown of Market Segments in DNA Manufacturing
This market is segmented by type, grade, application, and end-use sectors. Key types include plasmid DNA, synthetic DNA, gene synthesis, and oligonucleotide synthesis.
Grades are divided into Good Manufacturing Practices (GMP) and Research and Development (R&D) categories. Applications cover cell and gene therapy, vaccines, oligonucleotide-based drugs, and other uses. End-users consist of pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations (CROs).
Subsegments provide further detail: plasmid DNA types include GMP-grade and non-GMP-grade varieties, high and low copy number plasmids, bacterial fermentation-derived plasmids, and transfection-grade plasmids. Synthetic DNA breaks down into enzymatic and chemical synthesis methods, long and short DNA fragments, and single- or double-stranded DNA. Gene synthesis covers custom and standard synthesis, complex gene constructs, codon optimization, and gene library synthesis. Oligonucleotide synthesis includes DNA oligos, modified oligos, long oligos, PCR primers, siRNA and antisense oligos, and adapter and linker oligos.

Geographical Distribution and Outlook
While the report does not detail regional specifics here, the DNA manufacturing market's growth is globally influenced by biotechnology hubs and pharmaceutical R&D centers. Regions with advanced healthcare infrastructure and investment in gene therapies are expected to lead market expansion in the coming years.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.